专利检索 ap:("Markus Henrich" OR "Tanja Weil" OR "Sibylle Muller" OR "Jens Nagel" OR "Andreas Gravius" OR "Valerjans Kauss" OR "Ronalds Zemribo" OR "Elina Erdmane") AND inv:"Elina Erdmane" 第 1 页

1.

发明申请
PYRAZOLOPYRIMIDINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINE 审中-公开
标题翻译：吡咯并嘧啶，其制备方法及其作为医药使用

公开(公告)号：US20110003820A1

公开(公告)日：2011-01-06

申请号：US12735605

申请日：2009-01-30

申请人： Markus Henrich , Tanja Weil , Sibylle Muller , Jens Nagel , Andreas Gravius , Valerjans Kauss , Ronalds Zemribo , Elina Erdmane

发明人： Markus Henrich , Tanja Weil , Sibylle Muller , Jens Nagel , Andreas Gravius , Valerjans Kauss , Ronalds Zemribo , Elina Erdmane

IPC分类号： A61K31/519 , C07D487/04 , A61K31/5025 , A61K31/53 , A61P25/00 , A61P35/00

CPC分类号： C07D519/00 , C07D487/04

摘要： The invention relates to pyrazolopyrimidine derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are mGluR5 modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.

摘要翻译： 本发明涉及吡唑并嘧啶衍生物及其药学上可接受的盐。本发明还涉及制备这些化合物的方法。本发明的化合物是mGluR5调节剂，因此可用于控制和预防急性和/或慢性神经障碍。

2.

发明申请
METABOTROPIC GLUTAMATE RECEPTOR MODULATORS 审中-公开
标题翻译：代谢谷氨酸受体调节剂

公开(公告)号：US20120178742A1

公开(公告)日：2012-07-12

申请号：US13388776

申请日：2010-08-03

申请人： Markus Henrich , Tanja Weil , Mirko Hechenberger , Sibylle Muller , Valerjans Kauss , Ronalds Zemribo , Elina Erdmane , Gints Smits

发明人： Markus Henrich , Tanja Weil , Mirko Hechenberger , Sibylle Muller , Valerjans Kauss , Ronalds Zemribo , Elina Erdmane , Gints Smits

IPC分类号： A61K31/55

CPC分类号： C07D471/04 , C07D487/04 , C07D498/04 , C07D513/04

摘要： The invention relates to heterocyclic derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are mGluR5 modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.

摘要翻译： 本发明涉及杂环衍生物及其药学上可接受的盐。本发明还涉及制备这些化合物的方法。本发明的化合物是mGluR5调节剂，因此可用于控制和预防急性和/或慢性神经障碍。

3.

发明申请
Metabotropic glutamate receptor modulators 审中-公开
标题翻译：代谢型谷氨酸受体调节剂

公开(公告)号：US20070299113A1

公开(公告)日：2007-12-27

申请号：US11821492

申请日：2007-06-22

申请人： Ivars Kalvinsh , Larisa Kaulina , Valerjans Kauss , Ronalds Zemribo , Wojciech Danysz , Markus Henrich , Christopher Graham Raphael Parsons , Tanja Weil , Elina Erdmane

发明人： Ivars Kalvinsh , Larisa Kaulina , Valerjans Kauss , Ronalds Zemribo , Wojciech Danysz , Markus Henrich , Christopher Graham Raphael Parsons , Tanja Weil , Elina Erdmane

IPC分类号： A61K31/4439 , A61K31/43 , C07D498/04

CPC分类号： C07D513/04

摘要： The invention relates to imidazothiazole derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are group I mGluR modulators and are therefore useful for the control and prevention of various disorders, including acute and/or chronic neurological disorders.

摘要翻译： 本发明涉及咪唑并噻唑衍生物及其药学上可接受的盐。本发明还涉及制备这些化合物的方法。本发明的化合物是I组mGluR调节剂，因此可用于控制和预防各种疾病，包括急性和/或慢性神经障碍。